Obesity affects approximately 100 million Indian adults and is linked to over 200 health complications, including heart ...

Eli Lilly (LLY) launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk (NVO) for a much-awaited entry into the world’s most populous country ...

US pharma giants eye India’s obesity crisis with pricey shots, sparking ‘Make in India’ and affordability debates ...

US giant, Eli Lilly launched Mounjaro (tirzepatide) which is a prescription medicine for adults with type 2 diabetes used ...

Pharma giant Eli Lilly has launched a new anti-obesity and diabetes drug in India called Mounjaro. But should you take ...

Eli Lilly and Company launched its weight loss drug Mounjaro in India on Thursday after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO). This is a drug which ...

In a big breakthrough, Eli Lilly has launched its diabetes and weight-loss drug Mounjaro in India following approval from the ...

The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the pharmaceutical giant Eli Lilly on Thursday announcing the launch of tirzepatide ...

American pharmaceutical company Eli Lilly has launched its drug, Mounjaro, in India. Mounjaro is administered as a ...

American Drugmaker Eli Lilly on Thursday announced the launch its blockbuster drug Mounjaro in India beating its rival Novo Nordisk. Both the companies have seen skyrocketing global demand for ...

Eli Lilly launched its weight loss drug Mounjaro in India. According to the company, the injection is supposed to be taken once every week and will be available in 2.5mg and 5 mg vials.

ELi Lilly Weight Loss Drug: Popular anti-diabetes and obesity drug Mounjaro has been launched in India in a single-dose vial. While it has already been in strong demand in the US and Europe, the India ...